Today: 20 March 2026
BP share price dips as Trump tariff threat jars Europe and oil eases
19 January 2026
2 mins read

BP share price dips as Trump tariff threat jars Europe and oil eases

London, Jan 19, 2026, 09:03 GMT — Regular session

  • BP shares dipped 0.2% in early London trading as investors offloaded risk assets across Europe
  • Oil prices dropped amid signs of a swift unwinding of the “Iran premium” in crude
  • Tariff headlines are in focus this week as markets await BP’s Feb. 10 results, looking for clues on buybacks and cash returns

BP shares (BP.L) slipped slightly on Monday, last seen down 0.2% at 439.35 pence. Earlier, the stock fluctuated between 435.95 and 439.60 pence during the session. At 0818 GMT, it was trading 0.90 pence below the prior close, based on delayed market data. shareprices.com

The shift was more about the market than the company. Investors dumped European stocks following renewed tariff threats from Washington, reigniting trade-war jitters and dragging major players like BP down with them.

The pan-European STOXX 600 dropped 1.3%, while London’s FTSE 100 slipped 0.4% after U.S. President Donald Trump threatened fresh tariffs tied to his push for the U.S. to buy Greenland. According to Reuters, Trump announced plans to slap an extra 10% tariff starting Feb. 1 on imports from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland, and Britain — climbing to 25% on June 1 if no agreement is reached. Reuters

Oil, another key mover for major integrated producers, also eased. By 0734 GMT, Brent dipped 28 cents to $63.85 a barrel, while U.S. West Texas Intermediate dropped 36 cents to $59.08. Traders pointed to calming unrest in Iran, which trimmed the geopolitical “risk premium” — the extra cost investors build in for potential supply interruptions. IG market analyst Tony Sycamore noted the pullback came as that Iran premium unwound quickly. Vandana Hari, founder of Vanda Insights, predicted “rangebound movement” ahead, with U.S. markets closed for Martin Luther King Jr. Day. Reuters

For BP, a softer crude price backdrop can sap momentum from the sector, even when there’s little company-specific news. Shell and TotalEnergies tend to track the same blend of oil prices and overall risk sentiment, which Monday’s early trading reflected.

Deutsche Bank’s George Saravelos flagged concerns that the “weaponisation of capital” could wreak more havoc than tariffs by themselves, as traders considered Europe’s potential moves if tensions escalate. Some strategists had already shifted focus from trade flows to the underlying mechanics of global markets. Reuters

That said, the situation can shift quickly. Should tariff threats become policy and chip away at growth forecasts, oil demand forecasts could weaken, dragging down energy stocks. On the flip side, a geopolitical turn could stoke supply worries, pushing crude prices higher.

BP’s next major event is its full-year results on Feb. 10. Investors will be watching closely for any shifts in cash returns or buybacks following the recent trading update. RBC analyst Biraj Borkhataria weighed in last week, saying the update felt like new management was “clearing the decks.” He suggested a deeper cut in buybacks could come next. Reuters

Traders will watch tariff developments tied to the World Economic Forum in Davos while tracking crude’s moves, ahead of U.S. markets reopening Tuesday following the holiday.

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
BAE Systems share price rises after buyback update as defence stocks hold up
Previous Story

BAE Systems share price rises after buyback update as defence stocks hold up

NatWest share price slips as Trump tariff threat hits Europe; NWG stock eyes Feb 13 results
Next Story

NatWest share price slips as Trump tariff threat hits Europe; NWG stock eyes Feb 13 results

Go toTop